Targeted Strategies for Today's Evolving Markets

MissionIR Blog

Category Archives: Cardium Therapeutics Inc. CXM

Cardium Therapeutics, Inc. (CXM) Strategic Business Model Employs Diverse Product Lineup

Cardium Therapeutics is a health sciences and regenerative medicine company strategizing to acquire and develop new and innovative bio-medical product opportunities that have definable pathways to commercialization, partnering, sale, or other economic monetizations. To avoid the risk of relying on … Continue reading

Posted in Cardium Therapeutics Inc. CXM | Leave a comment

Cardium Therapeutics, Inc. (CXM) Forges Ahead Through Strategic Acquisition and Late-Stage Product Development

Asset-based health sciences and regenerative medicine company Cardium Therapeutics operates under a business model that involves creating multiple success opportunities without relying on any one technology platform or product type. Focused on acquiring and strategically developing new and innovative biomedical … Continue reading

Posted in Cardium Therapeutics Inc. CXM | Leave a comment

Cardium Therapeutics, Inc. (CXM) Enhances Well-being with Family of Nutraceutical Supplement Products

Cardium Therapeutics is an asset-based health sciences and regenerative medicine company that focuses on new and innovative bio-medical product opportunities and businesses that have potential to address significant unmet medical needs. The company seeks to acquire, develop and leverage multiple … Continue reading

Posted in Cardium Therapeutics Inc. CXM | Leave a comment

Cardium Therapeutics, Inc.’s (CXM) Generx® Addresses Global Cardiac Threat with Revolutionary Potential

Cardium Therapeutics has developed a unique portfolio of businesses and product opportunities in the fields of health sciences and regenerative medicine. Among other opportunities in its portfolio, the company’s lead clinical development product candidate, Generx®, is being developed to treat … Continue reading

Posted in Cardium Therapeutics Inc. CXM | Leave a comment

Cardium Therapeutics, Inc. (CXM) Pursuit for Growth Anchored by Key Elements, Strategic Design

As an asset-based health sciences and regenerative medicine company, Cardium Therapeutics focuses on acquiring and developing innovative products and businesses that have the potential to fulfill significant unmet medical needs. In its quest to develop a portfolio of medical product … Continue reading

Posted in Cardium Therapeutics Inc. CXM | Leave a comment

Cardium Therapeutics Inc. (CXM) Executes Defined Strategy to Meet Unmet Medical Needs, Expands Bio-Medical Business Portfolio

Cardium Therapeutics is a health sciences and regenerative medicine company building a portfolio of bio-medical opportunities and businesses with a definable pathway to commercialization and the potential to revolutionize the healthcare industry by meeting unmet medical needs. The company’s flagship … Continue reading

Posted in Cardium Therapeutics Inc. CXM | Leave a comment

Cardium Therapeutics, Inc. (CXM) Advances Biomedicine through Acquisition and Strategic Development

Asset-based health sciences and regenerative medicine company Cardium Therapeutics is focused on acquiring and strategically developing new and innovative biomedical product opportunities and businesses. The company acquires and develops opportunities and businesses that have the potential to address significant unmet … Continue reading

Posted in Cardium Therapeutics Inc. CXM | Leave a comment

Cardium Therapeutics Inc. (CXM) Business Strategy Builds on Key Elements, Diverse Portfolio

Cardium Therapeutics is engaged in the acquisition and development of innovative products that fall within a set range of criterion, focused on products and businesses that have demonstrated their potential to address significant unmet medical needs and having a definable … Continue reading

Posted in Cardium Therapeutics Inc. CXM | Leave a comment

Cardium Therapeutics, Inc. (CXM) Subsidiary Shows Support for Life Insurance Awareness Month

LifeAgain Insurance Solutions, a wholly owned subsidiary of Cardium Therapeutics, today announced its support of Life Insurance Awareness Month. Taking place during September, this campaign is sponsored by the Life and Health Insurance Foundation for Education (LIFE). LIFE’s aim is … Continue reading

Posted in Cardium Therapeutics Inc. CXM | Leave a comment

Cardium Therapeutics, Inc. (CXM) Subsidiary Launches First Life Insurance Program Developed For Men with Active Localized Prostate Cancer

Cardium Therapeutics just announced that LifeAgain™ Insurance Solutions Inc., a wholly-owned subsidiary, and AgencyONE, its commercialization partner, have entered into agreements to market and sell term life insurance issued by Symetra Life Insurance Company under LifeAgain’s BlueMetric Select™ term life … Continue reading

Posted in Cardium Therapeutics Inc. CXM | Leave a comment